Haemonetics Corporation (HAE)

Haemonetics Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 28, 2024	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022	Apr 3, 2021	Mar 28, 2020
Cash & Equivalents	299.28	178.8	284.47	259.5	192.31	137.31
Trading Asset Securities	0.74	1.67	1.11	-	-	-
Cash & Short-Term Investments	300.03	180.47	285.58	259.5	192.31	137.31
Cash Growth	-15.15%	-36.80%	10.05%	34.94%	40.05%	-18.92%
Receivables	213.53	206.56	179.14	159.38	127.56	165.21
Inventory	382.11	317.2	259.38	293.03	322.61	270.28
Prepaid Expenses	60.2	63.16	43.92	40.9	48.91	29.63
Other Current Assets	0.03	1.51	1.7	3.23	2.17	1.22
Total Current Assets	955.9	768.9	769.72	756.03	693.55	603.64
Property, Plant & Equipment	300.48	366.63	364.3	311.23	277.42	305.64
Long-Term Investments	10.9	0.06	-	-	-	-
Goodwill	616.16	565.08	466.23	467.29	466.44	210.65
Other Intangible Assets	487.84	406.12	275.77	310.26	365.48	133.11
Long-Term Deferred Tax Assets	9.08	7.74	5.24	4.47	6.01	3.93
Other Long-Term Assets	144.86	81.06	53.56	10.46	11.03	10.15
Total Assets	2,525	2,196	1,935	1,860	1,820	1,267
Accounts Payable	69.24	73.36	63.93	58.37	50.29	50.73
Accrued Expenses	49.3	80.71	64.48	48.54	52.03	52.75
Current Portion of Long-Term Debt	5.43	10.23	11.78	215.96	22.57	82.56
Current Portion of Leases	-	8.13	7.16	7.2	7.71	7.31
Current Income Taxes Payable	-	-	-	-	19.23	13.29
Current Unearned Revenue	36.7	31.24	30.21	26.81	26.27	28.84
Other Current Liabilities	113.27	96.71	74.26	85.39	75.4	39.34
Total Current Liabilities	273.95	300.38	251.82	442.27	253.5	274.82
Long-Term Debt	1,221	797.56	755.91	559.44	694.89	314.99
Long-Term Leases	88.23	57.96	55.9	55.7	62.96	52.01
Long-Term Deferred Tax Liabilities	62.89	62.64	36.2	28.73	43.83	10.56
Other Long-Term Liabilities	-	17.08	17.01	24.17	33.08	14.53
Total Liabilities	1,646	1,236	1,117	1,110	1,088	680
Common Stock	0.5	0.51	0.5	0.51	0.51	0.5
Additional Paid-In Capital	544.38	634.63	594.71	572.48	602.73	553.23
Retained Earnings	368.54	360.46	253.17	202.39	157.98	78.51
Comprehensive Income & Other	-34.56	-35.63	-30.38	-25.95	-29.55	-45.14
Shareholders' Equity	878.85	959.96	818	749.42	731.67	587.11
Total Liabilities & Equity	2,525	2,196	1,935	1,860	1,820	1,267
Total Debt	1,315	873.88	830.76	838.3	788.13	456.87
Net Cash (Debt)	-1,015	-693.41	-545.18	-578.81	-595.82	-319.56
Net Cash Per Share	-19.74	-13.49	-10.60	-11.27	-11.62	-6.17
Filing Date Shares Outstanding	50.22	50.84	50.54	51.28	50.95	50.39
Total Common Shares Outstanding	50.38	50.79	50.45	51.12	50.87	50.32
Working Capital	681.96	468.52	517.91	313.77	440.05	328.82
Book Value Per Share	17.44	18.90	16.21	14.66	14.38	11.67
Tangible Book Value	-225.15	-11.24	76	-28.12	-100.26	243.35
Tangible Book Value Per Share	-4.47	-0.22	1.51	-0.55	-1.97	4.84
Land	3.76	4.13	5.36	5.17	5.12	4.78
Buildings	124.26	124.34	127.63	104.36	107.32	101.3
Machinery	786.18	791.02	781.86	706.01	704.82	726.36
Construction In Progress	24.89	39.69	29.37	53.61	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.